Innocoll stock slides 65% after FDA setback for pain treatment By: MarketWatch December 30, 2016 at 11:10 AM EST Analysts downgrade the stock on concerns the company could run out of money as it works to satisfy FDA requirements. Read More >> Related Stocks: Pacira Pharm Inc